Literature DB >> 31486233

Review: Other Helicobacter species.

Armelle Ménard1, Annemieke Smet2.   

Abstract

This article is a review of the most important, accessible, and relevant literature published between April 2018 and April 2019 in the field of Helicobacter species other than Helicobacter pylori. The initial part of the review covers new insights regarding the presence of gastric and enterohepatic non-H. pylori Helicobacter species (NHPH) in humans and animals, while the subsequent section focuses on the progress in our understanding of the pathogenicity and evolution of these species. Over the last year, relatively few cases of gastric NHPH infections in humans were published, with most NHPH infections being attributed to enterohepatic Helicobacters. A novel species, designated "Helicobacter caesarodunensis," was isolated from the blood of a febrile patient and numerous cases of human Helicobacter cinaedi infections underlined this species as a true emerging pathogen. With regard to NHPH in animals, canine/feline gastric NHPH cause little or no harm in their natural host; however they can become opportunistic when translocated to the hepatobiliary tract. The role of enterohepatic Helicobacter species in colorectal tumors in pets has also been highlighted. Several studies in rodent models have further elucidated the mechanisms underlying the development of NHPH-related disease, and the extra-gastric effects of a Helicobacter suis infection on brain homeostasis was also studied. Comparative genomics facilitated a breakthrough in the evolutionary history of Helicobacter in general and NHPH in particular. Investigation of the genome of Helicobacter apodemus revealed particular traits with regard to its virulence factors. A range of compounds including mulberries, dietary fiber, ginseng, and avian eggs which target the gut microbiota have also been shown to affect Helicobacter growth, with a potential therapeutic utilization and increase in survival.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  animal studies; genomics and evolution; human and animal disease; non-Helicobacter pylori Helicobacter; pathogenesis

Mesh:

Year:  2019        PMID: 31486233     DOI: 10.1111/hel.12645

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  7 in total

1.  Diesel exhaust particles alter the profile and function of the gut microbiota upon subchronic oral administration in mice.

Authors:  Sybille van den Brule; Margaux Rappe; Jérôme Ambroise; Caroline Bouzin; Chantal Dessy; Adrien Paquot; Giulio G Muccioli; Dominique Lison
Journal:  Part Fibre Toxicol       Date:  2021-02-09       Impact factor: 9.400

2.  Helicobacter cinaedi bacteraemia secondary to enterocolitis in an immunocompetent patient.

Authors:  Sofie Larsen Rasmussen; Iben Ørsted; Irene Harder Tarpgaard; Hans Linde Nielsen
Journal:  Gut Pathog       Date:  2021-04-23       Impact factor: 4.181

3.  Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.

Authors:  Matic Mihevc; Metka Koren Krajnc; Maja Bombek Ihan; Iztok Holc
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-04-08       Impact factor: 3.944

4.  Specific gut microbiota alterations in essential tremor and its difference from Parkinson's disease.

Authors:  Pingchen Zhang; Pei Huang; Juanjuan Du; Yixi He; Jin Liu; Guiying He; Shishuang Cui; Weishan Zhang; Gen Li; Shengdi Chen
Journal:  NPJ Parkinsons Dis       Date:  2022-08-05

5.  Salidroside Improves Antibiotic-Induced Gut Microbiota Disturbance and Low Levels of Short-Chain Fatty Acids in Mice.

Authors:  Tong Sun; Jingyi Yang; Lili Lu
Journal:  Foods       Date:  2022-10-03

6.  Pan-Genome-Assisted Computational Design of a Multi-Epitopes-Based Vaccine Candidate against Helicobacter cinaedi.

Authors:  Saba Ismail; Noorah Alsowayeh; Hyder Wajid Abbasi; Aqel Albutti; Muhammad Tahir Ul Qamar; Sajjad Ahmad; Rabail Zehra Raza; Khulah Sadia; Sumra Wajid Abbasi
Journal:  Int J Environ Res Public Health       Date:  2022-09-14       Impact factor: 4.614

7.  Diet Supplementation with Fish-Derived Extracts Suppresses Diabetes and Modulates Intestinal Microbiome in a Murine Model of Diet-Induced Obesity.

Authors:  Konstantinos Axarlis; Maria G Daskalaki; Sofia Michailidou; Nikolais Androulaki; Antiopi Tsoureki; Evangelia Mouchtaropoulou; Ourania Kolliniati; Ioanna Lapi; Eirini Dermitzaki; Maria Venihaki; Katerina Kousoulaki; Anagnostis Argiriou; Zouhir El Marsni; Christos Tsatsanis
Journal:  Mar Drugs       Date:  2021-05-11       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.